1,443 results
1,443 results
Explore creators, their resources and related reviews to research your next step.
Alek Petrov
0.0
AI productivity YouTuber with over 150,000 subscribers who specializes in advanced ChatGPT prompting techniques, AI workflow optimization, and productivity system design. Alek creates highly detailed content on prompt engineering, AI-assisted content creation, and building sophisticated AI-powered workflows for knowledge workers. His channel focuses on the technical aspects of AI productivity, including advanced prompting strategies, multi-step AI processes, and integrating various AI tools into cohesive productivity systems. Alek content is particularly valuable for power users who want to maximize the potential of AI tools through expert-level techniques. He covers topics like advanced GPT usage, AI research methodologies, automated content pipelines, and AI-powered project management systems. His approach combines deep technical knowledge with practical applications for serious productivity enthusiasts.
Jeff Su
0.0
Former Bain & Company consultant turned productivity YouTuber with over 400,000 subscribers who focuses on AI-powered productivity workflows and professional development. Jeff creates content on leveraging AI tools like ChatGPT, Claude, and various AI platforms to enhance workplace productivity, improve presentations, and streamline consulting-style analysis. His background in management consulting brings a structured, results-oriented approach to AI productivity content. Jeff covers topics like AI-assisted data analysis, automated report generation, strategic planning with AI, and integrating AI into professional workflows. He combines consulting frameworks with modern AI tools to help professionals work more efficiently and deliver higher-quality outputs. His content is particularly valuable for knowledge workers, consultants, and business professionals looking to integrate AI into their daily work routines.
Dr. Isaac Kohane
0.0
Professor of Biomedical Informatics at Harvard Medical School and a pioneer in applying artificial intelligence to pediatric healthcare and medical research. Dr. Kohane has been at the forefront of developing AI systems for clinical decision support, electronic health record analysis, and precision medicine. His research focuses on using machine learning and natural language processing to extract insights from clinical data and improve patient outcomes. He has been instrumental in advancing the field of biomedical informatics and has published extensively on topics including AI applications in healthcare, genomic medicine, and clinical data analytics. Dr. Kohane has founded multiple companies and research initiatives that translate AI research into practical clinical applications. His work includes developing predictive models for disease diagnosis, treatment optimization, and population health management. He is particularly known for his contributions to pediatric informatics and his efforts to ensure that AI systems are safe and effective for vulnerable patient populations. His expertise spans computer science, medicine, and public health, making him a leading voice in the responsible development and deployment of healthcare AI.
Dr. Atul Butte
0.0
Professor and Chief Data Scientist at UCSF Health, specializing in biomedical data science and AI applications in precision medicine. Dr. Butte has pioneered the use of large-scale biomedical datasets and artificial intelligence to identify new therapeutic targets and improve patient care. His research focuses on translating biomedical big data into actionable insights for drug discovery, disease understanding, and personalized treatment strategies. He has founded several companies based on his research findings and has been instrumental in developing computational methods for analyzing genomics, proteomics, and clinical data. Dr. Butte work includes using AI to repurpose existing drugs for new indications, identifying biomarkers for disease diagnosis and prognosis, and developing precision medicine approaches. He has published extensively on computational biology, biomedical informatics, and the application of machine learning to healthcare challenges. His expertise spans from basic biological research to clinical applications, making him a bridge between computational innovation and medical practice. He is a frequent speaker on the future of precision medicine and the role of AI in transforming healthcare delivery.
Dr. Nigam Shah
0.0
Associate Professor of Medicine and Director of the AIMI (Stanford AI for Medicine and Imaging) Center at Stanford University. Dr. Shah is a leading researcher in applying artificial intelligence and machine learning to clinical medicine and healthcare. His work focuses on developing AI systems that can extract insights from electronic health records, predict patient outcomes, and support clinical decision-making. He has published extensively on topics including natural language processing for medical records, predictive modeling in healthcare, and the responsible deployment of AI in clinical settings. Dr. Shah leads research initiatives that aim to make AI tools practical and beneficial for clinicians and patients. His expertise spans biomedical informatics, machine learning applications in medicine, and the ethical implications of healthcare AI. He has been involved in developing AI models for drug discovery, clinical outcome prediction, and population health analytics. His work emphasizes the importance of creating AI systems that are transparent, interpretable, and trustworthy for use in healthcare settings where human lives are at stake.
Dr. Adrian Aoun
0.0
Founder and CEO of Forward Health, a company reimagining primary care through AI and advanced technology. Dr. Aoun has created a healthcare model that combines artificial intelligence, biometric monitoring, and personalized medicine to provide comprehensive preventive care. Forward Health clinics use AI-powered diagnostic tools, continuous health monitoring, and predictive analytics to detect health issues before they become serious problems. His vision integrates advanced medical technology, including body scanners, genetic testing, and real-time health monitoring, into routine primary care. Under his leadership, Forward has developed AI systems that can analyze vast amounts of health data to provide personalized health insights and treatment recommendations. Dr. Aoun has a background in technology and healthcare innovation, with previous experience at companies including Google and Sidewalk Labs. He advocates for a proactive approach to healthcare that uses AI and technology to prevent disease rather than just treat it. His work represents a new paradigm in healthcare delivery that combines cutting-edge technology with personalized, patient-centered care.
Dr. Serafim Batzoglou
0.0
Chief Data Officer at Insitro and former Professor of Computer Science at Stanford University, specializing in computational biology and AI for drug discovery. Dr. Batzoglou has pioneered the development of machine learning algorithms for analyzing genomic data and understanding biological systems. His research has been fundamental in advancing computational methods for genome assembly, population genetics, and personalized medicine. At Insitro, he leads efforts to apply artificial intelligence and machine learning to drug discovery, working to identify new therapeutic targets and optimize drug development processes. His work includes developing AI models that can predict drug efficacy, identify patient populations most likely to benefit from specific treatments, and accelerate the translation of biological insights into clinical applications. Dr. Batzoglou has published extensively on computational genomics, machine learning in biology, and bioinformatics. His expertise spans algorithm development, statistical analysis of biological data, and the application of AI to solve complex problems in biotechnology and pharmaceutical research. He has been involved in numerous collaborative research projects and has contributed to the development of widely-used computational tools for biological research.
Dr. Vijay Pande
0.0
General Partner at Andreessen Horowitz (a16z) and former Professor of Chemistry at Stanford University, specializing in computational biology and AI for drug discovery. Dr. Pande founded the Folding@home distributed computing project, which uses millions of computers worldwide to simulate protein folding and drug interactions. His work has been instrumental in advancing our understanding of molecular dynamics and applying computational methods to drug discovery. At a16z, he leads investments in biotech and healthcare companies leveraging artificial intelligence, machine learning, and computational biology. His expertise spans biophysics, computational chemistry, and the application of AI to solve complex biological problems. Dr. Pande has been a pioneer in using distributed computing and machine learning for scientific research, particularly in understanding disease mechanisms and developing new therapeutics. He has published extensively on computational methods for studying protein folding, drug design, and molecular simulations. His transition from academia to venture capital allows him to support the next generation of companies using AI to transform medicine and biotechnology.
Dr. Shereef Elnahal
0.0
Under Secretary for Health at the U.S. Department of Veterans Affairs and a champion of AI adoption in healthcare systems. Dr. Elnahal has led major initiatives to implement artificial intelligence and machine learning across the VA healthcare network, one of the largest healthcare systems in the United States. His work focuses on using AI to improve veteran care, reduce administrative burdens on healthcare workers, and enhance clinical decision-making. Under his leadership, the VA has deployed AI systems for predictive analytics, clinical documentation, and population health management. He has been instrumental in developing AI governance frameworks for healthcare organizations and establishing standards for the responsible deployment of AI in clinical settings. Dr. Elnahal regularly speaks about the transformative potential of AI in healthcare delivery and the importance of maintaining human-centered care while leveraging technology. His experience includes overseeing large-scale digital health transformations and ensuring that AI implementations improve both provider experience and patient outcomes. He advocates for evidence-based AI adoption that addresses real healthcare challenges while maintaining safety and efficacy standards.
Munjal Shah
0.0
Co-founder and CEO of Hippocratic AI, a company developing large language models specifically for healthcare applications. Shah has a background in computer vision and AI, having previously founded and led several successful technology companies. At Hippocratic AI, he focuses on creating AI systems that can safely and effectively support healthcare workers and improve patient outcomes. The company mission is to develop AI that can democratize access to healthcare by providing intelligent support for medical professionals and patients. Shah has experience in scaling AI technologies and understands the unique challenges of implementing AI in healthcare settings. His vision for Hippocratic AI includes developing AI assistants that can help with medical education, patient monitoring, clinical decision support, and healthcare administration. He regularly speaks about the potential of large language models in healthcare and the importance of safety, accuracy, and ethical considerations when deploying AI in medical contexts. His work represents an effort to bring the latest advances in AI to healthcare in a responsible and beneficial way.
John Mattison
0.0
Chief Medical Information Officer at Kaiser Permanente and a leading expert in healthcare AI implementation and digital transformation. Dr. Mattison has been instrumental in deploying AI systems across one of the largest integrated healthcare systems in the United States. His work focuses on the practical application of artificial intelligence and machine learning to improve patient outcomes, reduce costs, and enhance clinical workflows. He has overseen the implementation of AI systems for clinical decision support, predictive analytics, and population health management across Kaiser Permanente extensive network. Dr. Mattison is a frequent speaker at healthcare technology conferences and has published extensively on topics including AI governance in healthcare, the integration of AI into clinical practice, and the challenges of scaling healthcare AI solutions. His expertise includes electronic health record optimization, telemedicine implementation, and the development of AI-powered clinical tools. He advocates for evidence-based approaches to healthcare AI adoption and has been involved in establishing standards for AI validation and deployment in clinical settings.
Dr. Sean Mooney
0.0
Professor of Biomedical Informatics at the University of Washington and Director of the Biomedical Data Science Program. Dr. Mooney specializes in applying machine learning and AI to solve complex problems in precision medicine, pharmacology, and population health. His research focuses on developing computational methods for drug discovery, predicting drug effects, and understanding disease mechanisms using large-scale biomedical data. He has published extensively on topics including network medicine, systems pharmacology, and the application of AI to clinical decision support. Dr. Mooney leads interdisciplinary research teams that combine computer science, medicine, and biology to create practical AI tools for healthcare. His work includes developing machine learning models for predicting drug toxicity, identifying new therapeutic targets, and optimizing treatment protocols. He is actively involved in training the next generation of biomedical data scientists and frequently collaborates with pharmaceutical companies and clinical researchers. His expertise spans bioinformatics, computational biology, and the ethical implementation of AI systems in healthcare settings.
Something missing?